1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MTURN CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA PDE7A CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA HDHD2 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA RCOR2 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA NREP CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA H2AFY CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA PTOV1 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA ESRRG CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA CASP8AP2 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA KIF1A CTRPv2 pan-cancer AAC 0.18 2e-06
Download CSV